PharmaShots Weekly Snapshot (Sept 14 -18, 2020)

 PharmaShots Weekly Snapshot (Sept 14 -18, 2020)

PharmaShots Weekly Snapshot (Sept 14 -18, 2020)

1. AstraZeneca Reports Updated Results of Imfinzi in P-III Studies for NSCLC and ES-SCLC

Published: Sept 18, 2020 | Tags:  AstraZeneca, Reports, Updated Results, Imfinzi, P-III, Studies, NSCLC, ES-SCLC

2. Roche Reports Results of Actemra in P-III EMPACTA Study in Patients with COVID-19 Associated Pneumonia

Published: Sept 18, 2020 | Tags:  Roche, Actemra, EMPACTA study, COVID-19, Pneumonia, Ventilation, Biologic, COVID-19 associated pneumonia

3. AstraZeneca and MSD Report Five Year Data of Lynparza in P-III SOLO-1 Study for 1L Maintenance Treatment in Patients with BRCA-Mutated Ovarian Cancer

Published: Sept 18, 2020 | Tags: AstraZeneca, MSD, Report, Five Year, Data, Lynparza, P-III, SOLO-1, Study, 1L Maintenance Treatment, Patients, BRCA-Mutated, Ovarian Cancer

4. Roche Launches Elecsys Anti-SARS-CoV-2 S Test for COVID-19 Antibodies

Published: Sept 18, 2020 | Tags: Roche, Launches, Elecsys Anti-SARS-CoV-2 S, Test, COVID-19, Antibodies

5. Eli Lilly Collaborates with Amgen to Boost the Global Supply of its COVID-19 Therapies

Published: Sept 17, 2020 | Tags: Eli Lilly, Collaborates, Amgen, Boost, Global Supply, COVID-19 Therapies

6. AstraZeneca Acquires Dogma Therapeutics’ Oral PCSK9 Inhibitor Program

Published: Sept 17, 2020 | Tags: AstraZeneca, Acquires, Dogma Therapeutics, Oral, PCSK9 Inhibitor Program

7. Roche to Present its Oncology Portfolio at the ESMO Virtual Congress 2020

Published: Sept 17, 2020 | Tags: Roche, Present, Oncology Portfolio, ESMO, Virtual Congress 2020

8. Junshi and Wigen Collaborate to Develop and Commercialize Four Therapies Targeting Cancer Indications

Published: Sept 16, 2020 | Tags: Junshi, Wigen, Collaborate, Develop, Commercialize, Four Therapies, Targeting, Cancer Indications

9. Sorrento to Initiate P-I Study of STI-1499 in COVID-19 Positive Patients

Published: Sept 16, 2020 | Tags: Sorrento, Initiate, P-I, Study, STI-1499, COVID-19, Positive, Patients

10. Samsung Bioepis to Present P-III Exploratory Analyses Results of Aybintio (bevacizumab, biosimilar) at ESMO 2020

Published: Sept 16, 2020| Tags:  Samsung Bioepis, Present, P-III, Exploratory Analyses, Results, Aybintio, bevacizumab, biosimilar, ESMO 2020

11. Novartis Reports Results of Dual regimen in P-III COMBI-AD Study for Patients with Stage III Melanoma

Published: Sept 17, 2020 | Tags:  Novartis, Reports, Results, Dual regimen, P-III, COMBI-AD Study, Patients, Stage III Melanoma

12. Baxter Signs an Exclusive Distribution Agreement With bioMérieux for Acute Kidney Injury Diagnostic Test in the US and EU

Published: Sept 16, 2020 | Tags:  Baxter, Signs, Exclusive, Distribution, Agreement, bioMérieux, Acute Kidney Injury, Diagnostic Test, US, EU

13. Eli Lilly Reports POC Data of LY-CoV555 in P-II BLAZE-1 Study for COVID-19 in Outpatient Setting

Published: Sept 16, 2020 | Tags: Eli Lilly Reports POC Data of LY-CoV555 in P-II BLAZE-1 Study for COVID-19 in Outpatient Setting

14. Roche’s CINtec PLUS Cytology Test Receives the US FDA’s Approval to Aid Clinicians in Preventing Cervical Cancer

Published: Sept 15, 2020 | Tags: Roche, CINtec PLUS Cytology Test, Receives, US, FDA, Approval, Aid, Clinicians, Preventing, Cervical Cancer

15. Takeda to Divest TachoSil to Corza Health for ~$416M

Published: Sept 16, 2020 | Tags: Takeda, Divest, TachoSil, Corza Health, ~$416M

16. Gilead’s Magrolimab Receives the US FDA’s Breakthrough Therapy Designation for Myelodysplastic Syndrome

Published: Sept 15, 2020 | Tags: Gilead, Magrolimab, US FDA, Breakthrough Therapy Designation, Myelodysplastic Syndrome, 2020 European Hematology Society Congress

17. BMS Exercises its Option to Globally License Obsidian’s CD40L Cell Therapy

Published: Sept 15, 2020 | Tags: BMS, Exercises, Option, Globally, License, Obsidian, CD40L Cell Therapy

18.  Merck’s Brenzys (biosimilar, etanercept) Receives Health Canada Approval for Multiple Indications

Published: Sept 15, 2020 | Tags: Merck, Brenzys, biosimilar, etanercept, Receives, Health Canada, Approval, Multiple, Indications

19.  Boehringer Ingelheim Reports Results of BI 425809 in P-II Study for Schizophrenia

Published: Sept 14, 2020 | Tags: Boehringer Ingelheim, BI 425809, Schizophrenia, ECNP Congress, Cognitive Impairment, CNS

20. The US FDA Rejects Mallinckrodt’s Terlipressin Due to Doubts in its Risk-Benefit Profile

Published: Sept 14, 2020 | Tags: US, FDA, Rejects, Mallinckrodt, Terlipressin, Doubts, Risk-Benefit Profile

21. Novartis’ Beovu (brolucizumab) Receives EMA’s Approval for its Safety Label Update to Treat Wet Age-Related Macular Degeneration  

Published: Sept 14, 2020 | Tags: Novartis, Beovu, brolucizumab, EMA Approval, Label Update, Safety Label, Wet AMD, Retinal Vasculitis, Retinal Vascular Occlusion, Intraocular Inflammation

22. Janssen Collaborates with SpringWorks Therapeutics to Evaluate Nirogacestat + Teclistamab for Relapsed or Refractory Multiple Myeloma

Published: Sept 14, 2020 | Tags: Janssen, Collaborates, SpringWorks Therapeutics, Evaluate, Nirogacestat, Teclistamab, Relapsed, Refractory, Multiple Myeloma

23.  Eli Lilly and Incyte’s Olumiant + Gilead’s Veklury Reduce Time to Recovery in Hospitalized Patients with COVID-19

Published: Sept 14, 2020 | Tags: Eli Lilly, Incyte, Olumiant, Gilead, Veklury, Reduce Time, Recovery, Hospitalized Patients, COVID-19

24. Fitbit to Launch ECG App in the US and EU in October 2020

Published: Sept 14, 2020 | Tags: Fitbit, Launch, ECG App, US, EU, October, 2020, Fitbit Sense, AFib, ECG,

25. Merck Signs Up to $4.5B Oncology Deal with Seattle Genetics

Published: Sept 14, 2020 | Tags: Merck, Signs, Up to, $4.5B, Oncology Deal, Seattle Genetics

26. Boehringer Ingelheim and Click Collaborate on Digital Therapies for Behavior Modification in Schizophrenia

Published: Sept 13, 2020 | Tags:  Boehringer Ingelheim, Click Therapeutics, Collaborate, Digital Therapeutic, Behavior Modification, Schizophrenia

27. Novartis Reports Results of Beovu (brolucizumab) in P-III KITE Study for Diabetic Macular Edema

Published: Sept 13, 2020 | Tags: Novartis, Reports, Results, Beovu, (brolucizumab), P-III, KITE Study, Diabetic Macular Edema

28. Sanofi’s Dupixent Receives the US FDA’s Breakthrough Therapy Designation for Eosinophilic Esophagitis

Published: Sept 13, 2020 | Tags: Sanofi, Dupixent, Receives, US, FDA, Breakthrough Therapy Designation, Eosinophilic Esophagitis

29. AstraZeneca Resumes COVID-19 Vaccine Trials in the UK

Published: Sept 12, 2020 | Tags: AstraZeneca, Resumes, COVID-19 Vaccine, Trials, UK

30. Gilead to Acquire Immunomedics for ~$21B

Published: Sept 12, 2020 | Tags: Gilead, Acquire, Immunomedics, ~$21B

Related Post: PharmaShots Weekly Snapshot (Sept 07 -11, 2020)

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post